-
2 weeks ago | 
ajph.aphapublications.org | Eli Y. Adashi |Daniel O’Mahony |I. Glenn Cohen
Can't sign in? Forgot your password? Enter your email address below and we will send you the reset instructions If the address matches an existing account you will receive an email with instructions to reset your password.
-
1 month ago | 
jabfm.org | Eli Y. Adashi |Daniel O’Mahony |I. Glenn Cohen
Maternity Care Deserts: Key Drivers of the National Maternal Health Crisis Eli Y. Adashi, Daniel P. O’Mahony, I. Glenn Cohen The Journal of the American Board of Family Medicine Jan 2025, 38 (1) 165-167; DOI: 10.3122/jabfm.2024.240198R1
-
2 months ago | 
jabfm.org | Eli Y. Adashi |Daniel O’Mahony |I. Glenn Cohen
Health PolicyMaternal HealthMaternity Care DesertOn June 24, 2022, in the wake of its first-ever Maternal Health Day of Action, the White House released a strategic national action plan proposal titled “White House Blueprint for Addressing the Maternal Health Crisis.”1 The brainchild of Vice President Kamala D.
-
Nov 15, 2024 | 
healthaffairs.org | Carmel Shachar |Eli Y. Adashi
Crisis pregnancy centers (CPCs) often bill themselves as legitimate reproductive health care or medical clinics, but they are actually nonmedical centers, operated by anti-abortion advocates, that seek to convince pregnant people to choose parenting or adoption over abortion. To attract clients, CPCs—which are often religiously affiliated—may offer services including pregnancy testing and ultrasounds as well as social supports such as diapers.
-
Oct 11, 2024 | 
jamanetwork.com | Daniel Aaron |S.J. Quinney College |Eli Y. Adashi
On May 6, 2024, the US Food and Drug Administration (FDA) finalized a new rule to regulate laboratory-developed tests (LDTs). An LDT is a reagent, instrument, or system used for diagnosis or treatment that is designed, manufactured, and used by a single laboratory.1 LDTs are generally thought to fall within the legal definition of a medical device, which includes any “instrument” or “apparatus” for diagnosing disease.
-
Aug 14, 2024 | 
jabfm.org | former Dean |Eli Y. Adashi
Thank you for your interest in spreading the word on American Board of Family Medicine. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.
-
Apr 24, 2024 | 00052-1/fulltext&sz=64)
mayoclinicproceedings.org | Aditya Narayan |I. Glenn Cohen |Eli Y. Adashi
Abbreviations and Acronyms: DAP (diversity action plan), FDA (Food and Drug Administration), FDORA (Food and Drug Omnibus Reform Act of 2022), IVCT (in vitro clinical test), MoCRA (Modernization of Cosmetics Regulation Act of 2022), VALID (Verifying Accurate Leading-edge IVCT Development Act)On December 29, 2022, the Consolidated Appropriations Act, 2023 (Public Law No. 117-328) was signed into law, containing the Food and Drug Omnibus Reform Act of 2022 (FDORA), which introduces significant...
-
Feb 2, 2024 | 
healthaffairs.org | Eli Y. Adashi |Daniel O’Mahony |I. Glenn Cohen
According to federal government statistics, the “health care and social service industries experience the highest rates of injuries caused by workplace violence and are 5 times as likely to suffer a workplace violence injury than workers overall.” Health care workplace violence has been a persistent and growing concern for more than a decade.
-
Jan 10, 2024 | 
nature.com | Eli Y. Adashi |I. Glenn Cohen
As a matter of convention, same-sex human reproduction is deemed infeasible due to the absence of the requisite set of haploid gametes. Recently, however, it has become clear that bipaternal progeny may soon be technically possible thanks to the breakthrough science of in vitro gametogenesis (IVG)1. A disruptive reproductive technology in waiting, IVG has reached the point at which functional oocytes can be generated from male mice2.
-
Dec 18, 2023 | 00759-3/abstract&sz=64)
amjmed.com | I. Glenn Cohen |Eli Y. Adashi |Mary Ziegler
Financial Disclosures: Professor Cohen is a member of the ethics advisory board for Illumina and the Bayer Bioethics Council. He has also been compensated for speaking at events organized by Philips with the Washington Post. All authors authors had access to the data and a role in writing the manuscript. In the aftermath of the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Organization (Dobbs), bans on abortion have multiplied in conservative state legislatures.
